Perkasie, PA – Oct. 1, 2014 – Chris Glasby, Senior Manufacturing Engineer at Secant Medical, will present “Existing Textile Technology Matched with Material Innovation” during the medical track at the IFAIAdvanced Textiles Expo on Monday, October 13 at 3:15 pm. The presentation will address the use of advanced biomaterials in biomedical textile components and the challenges faced when engineered with current textile processes.
Glasby will provide a brief history of implantable textiles, including the leap from textiles engineered with synthetic materials, to resorbable materials and the development of regenerative tissue scaffolds. Glasby will also discuss the future of biomaterials, including the benefits and applications of the resorbable bioelastomer poly(glycerol sebacate) (PGS).
“I have been in the textile industry for more than 24 years and have seen firsthand the challenges that arise when integrating new or advanced biomaterials with traditional textile engineering,” said Glasby. “This conference will be an opportunity to show the textile industry how Secant Medical is overcoming these obstacles and developing next-generation biomedical textile structures.”
The Advanced Textiles Expo takes place October 14-16 in Minneapolis at the Minneapolis Convention Center. The Advanced Textiles Expo programming begins Monday, October 13.
About IFAI Advanced Textiles Expo: IFAI Specialty Fabrics Expo and the Advanced Textiles Expo is the largest specialty fabrics event in the Americas. These combined shows offer the broadest exposure to the foundation and the future of the entire specialty fabrics industry, with more than 400 exhibits covering more than 100,000 square feet. The education program is considered among the most comprehensive in the industry. Advanced Textiles programming offers an in-depth look at the latest achievements, innovative applications and technologies used in advanced textiles.
About Secant Medical: Secant Medical provides advanced biomaterials and biomedical textile structures to the medical device industry. We partner with clients to design, develop, and manufacture high-performance biomedical structures for applications in cardiovascular, neurovascular, orthopedic and general surgery. Built on a 70-year history, we’re committed to the future of regenerative medicine and actively engage in research partnerships to advance next-generation biomaterial technology into practical applications for the medical device and pharmaceutical industries. Secant Medical is a business unit of Fenner PLC, a worldwide leader in reinforced polymer engineering headquartered in Yorkshire, England. For more information, contact Maria Fontanazza at 215-257-8680 x2192 or [email protected]; or visit www.secantmedical.com.
View website
